Head-To-Head Review: Privia Health Group (PRVA) vs. Its Rivals

Privia Health Group (NASDAQ:PRVA) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its competitors? We will compare Privia Health Group to similar companies based on the strength of its analyst recommendations, valuation, dividends, risk, institutional ownership, profitability and earnings.

Institutional and Insider Ownership

94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 5.7% of Privia Health Group shares are owned by insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares Privia Health Group and its competitors revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Privia Health Group	$2.12 billion	$22.92 million	116.29
Privia Health Group Competitors	$21.02 billion	$288.54 million	12.92

Privia Health Group’s competitors have higher revenue and earnings than Privia Health Group. Privia Health Group is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Analyst Recommendations

This is a summary of current ratings and target prices for Privia Health Group and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0	3	9	0	2.75
Privia Health Group Competitors	1859	7720	13326	819	2.55

Privia Health Group currently has a consensus price target of $31.25, suggesting a potential upside of 27.97%. As a group, “Healthcare Providers & Services” companies have a potential upside of 14.51%. Given Privia Health Group’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Privia Health Group is more favorable than its competitors.

Risk & Volatility

Privia Health Group has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500. Comparatively, Privia Health Group’s competitors have a beta of 1.01, suggesting that their average share price is 1% more volatile than the S&P 500.

Profitability

This table compares Privia Health Group and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Privia Health Group	1.19%	3.52%	2.00%
Privia Health Group Competitors	-7.69%	-141.09%	-1.47%

Summary

Privia Health Group beats its competitors on 8 of the 13 factors compared.

About Privia Health Group

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.